On the 42nd anniversary of Operation Meghdoot, celebrated as Siachen Day, the Indian Air Force and Army paid homage to soldiers defending the world's highest battlefield. The operation was launched on ...

If you're going ... •The ninth annual Braveheart Testimonial Dinner is scheduled for April 19 at the New Englander Banquet Center, 3009 Wilmington Road. Doors open at 5 p.m., and dinner ...

While Donald Trump panders to MAGA, Iranian satire is reaching a global audience. On Sunday, as tens of millions of Orthodox Christians around the world observed Easter, the most important holy day on ...

Resurrection is still in the rearview mirror, a new behind-the-scenes development confirms that Dexter Resurrection Season 2 is not just a distant hope. The timeline update ...

If you're after crowd-pleasing epic movies, classics like The Great Escape, Seven Samurai, and The Lord of the Rings are all ...

A spokesperson for the events said: “A landmark cinematic moment will be celebrated in unforgettable style this spring as Mel ...

HRS-1893 (also known as BHB-1893) is a selective, small-molecule, cardiac myosin inhibitor engineered to improve heart performance in patients with HCM. By modulating cardiac contractility, HRS-1893 ...

Etched in ice, Operation Meghdoot was far more than a military campaign, it was a saga of unmatched grit and sacrifice. At the edge of the world, where survival itself is a battle, soldiers of the ...

Braveheart Bio Inc. reported positive results from an open-label randomized phase II dose-ranging study of BHB-1893 (HRS-1893) in obstructive hypertrophic cardiomyopathy. Results presented at the ...

Braveheart Auctions has donated the half-acre plot in the Highlands to the star - with the only clause that he joins staff for a "dram and a cold dip".

Catholic Cardinal Blase Cupich lambasted Trump's administration for posting "sickening" social media content about the Iran war during a 60 Minutes interview The post Catholic Cardinal Slams Trump ...

Our round-up of biotech financings is led this week by Braveheart Bio, a San Francisco biotech that has launched with $185 million, a lead drug for hypertrophic cardiomyopathy (HCM), and Biogen CEO ...